Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending September 14, 2024 (Week 37)
Reporting Area Chlamydia trachomatis infection §
Current weekPrevious 52 weeks Max †Cum YTD 2024 †Cum YTD 2023 †
U.S. Residents, excluding U.S. Territories 14,872 35,497 970,429 1,190,797
New England 643 1,172 31,004 38,541
Connecticut - 318 4,454 9,395
Maine 41 81 1,874 2,119
Massachusetts 466 647 19,137 20,449
New Hampshire 35 76 1,682 2,026
Rhode Island 101 389 2,982 3,592
Vermont - 33 875 960
Middle Atlantic 1,754 4,379 126,535 143,167
New Jersey - 767 20,260 25,832
New York (excluding New York City) 873 957 27,673 30,270
New York City - 1,565 41,930 47,967
Pennsylvania 881 1,168 36,672 39,098
East North Central 1,710 4,704 113,984 163,294
Illinois 49 1,438 19,675 50,532
Indiana 423 698 22,253 24,759
Michigan 214 1,020 20,640 30,400
Ohio 645 1,153 34,919 39,729
Wisconsin 379 533 16,497 17,874
West North Central 781 2,116 61,557 70,059
Iowa 115 313 8,295 9,898
Kansas 133 297 8,362 9,703
Minnesota - 486 13,458 15,592
Missouri 421 709 20,659 22,277
Nebraska - 225 5,678 6,559
North Dakota 42 87 2,156 2,462
South Dakota 70 108 2,949 3,568
South Atlantic 4,928 12,280 242,107 273,153
Delaware - 227 3,597 3,959
District of Columbia 65 188 4,779 6,078
Florida 1,742 6,933 77,303 80,505
Georgia 917 1,501 43,398 52,705
Maryland 671 1,016 22,020 25,678
North Carolina 1 1,435 37,722 47,699
South Carolina 708 820 23,470 23,640
Virginia 809 912 26,933 29,719
West Virginia 15 116 2,885 3,170
East South Central 891 2,748 42,420 77,534
Alabama 631 889 22,580 24,204
Kentucky 260 592 11,091 11,742
Mississippi - 1,006 8,749 14,505
Tennessee - 905 - 27,083
West South Central 483 4,645 134,244 163,166
Arkansas 170 399 11,026 13,013
Louisiana 255 768 23,474 26,466
Oklahoma 58 408 7,567 14,253
Texas - 3,261 92,177 109,434
Mountain 816 2,691 74,028 83,538
Arizona 358 889 26,793 29,585
Colorado - 857 16,803 18,549
Idaho 57 127 3,607 4,160
Montana 43 98 2,335 2,596
Nevada 205 514 11,401 11,284
New Mexico 10 235 5,067 8,105
Utah 143 255 7,101 7,911
Wyoming - 47 921 1,348
Pacific 2,866 5,049 144,550 178,345
Alaska 51 125 3,355 3,715
California 2,213 3,945 119,059 138,899
Hawaii - 146 - 4,529
Oregon 294 352 9,860 10,949
Washington 308 609 12,276 20,253
U.S. Territories - 135 667 3,726
American Samoa - 0 - -
Commonwealth of Northern Mariana Islands - 0 - -
Guam - 0 - -
Puerto Rico - 135 667 3,726
U.S. Virgin Islands - 0 - -
Non-U.S. Residents 2 4 28 39
Total 14,874 35,541 971,124 1,194,562
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2023 and 2024 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2022, only confirmed cases are published to align with the approved CSTE position statement 21-ID-06, whereas in previous years, all case classification statuses were published. This change may cause a decrease in published case counts when compared to previous years.